Bruton's Tyrosine Kinase Inhibitors [MoA] - N0000193934

Pharmacologic Code	N0000193934
Pharmacologic Name	Bruton's Tyrosine Kinase Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 5 products whose active ingredient are classified under the same pharmacologic class Bruton's Tyrosine Kinase Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0078-1483	Rhapsido	Non-Proprietary Name: Remibrutinib	Tablet	Oral	Novartis Pharmaceuticals Corporation	ACTIVE
	72579-011	Brukinsa	Non-Proprietary Name: Zanubrutinib	Capsule	Oral	Beone Medicines Usa, Inc.	ACTIVE
	0002-7026	Jaypirca	Non-Proprietary Name: Pirtobrutinib	Tablet, Coated	Oral	Eli Lilly And Company	ACTIVE
	72579-122	Brukinsa	Non-Proprietary Name: Zanubrutinib	Tablet, Film Coated	Oral	Beone Medicines Usa, Inc.	ACTIVE
	0002-6902	Jaypirca	Non-Proprietary Name: Pirtobrutinib	Tablet, Coated	Oral	Eli Lilly And Company	ACTIVE